Neutralisierung von niedermolekularem Heparin Kabi 2165 mit Protaminchlorid
- 1 November 1986
- journal article
- research article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 64 (22), 1171-1175
- https://doi.org/10.1007/bf01728455
Abstract
Low molecular weight (LMW) heparin Kabi 2165 possesses improved pharmacodynamic properties compared with conventional heparin. It is currently investigated in the prophylaxis of thromboembolism. The neutralization of Kabi 2165 by protamine chloride was analysed after i.v. injection of both the agent and the antidot in healthy persons. The anticoagulant effects of the LMW heparin on the activated partial thromboplastin time, thrombin, and thromboelastography are completely and immediately suppressed by protamine chloride. The inhibition of factor X a is antagonized up to 50%–60%. The bleeding time remained unaffected. The data indicate that protamine chloride may be used in clinical situations as an antidot to the LMW heparin Kabi 2165. A rebound phenomenon of the anticoagulant effect does not occur.This publication has 27 references indexed in Scilit:
- Anwendung von niedermolekularem Heparin bei HämodialysepatientenKlinische Wochenschrift, 1985
- Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxisKlinische Wochenschrift, 1984
- Beeinflussung der Blutgerinnung durch ein niedermolekulares HeparinDeutsche Medizinische Wochenschrift (1946), 1984
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Mechanism of heparin rebound: In vitro studyThrombosis Research, 1980
- A DOUBLE-BLIND TRIAL OF LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MYOCARDIAL INFARCTION*1The Lancet, 1973
- Die ThrombelastographieZeitschrift für Die Gesamte Experimentelle Medizin, 1951
- NEUTRALISATION OF ACTION OF HEPARIN BY PROTAMINEThe Lancet, 1939